Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Director's details changed for Anna Ellingboe on 2026-05-19
Notification of a person with significant control statement
Cessation of Erik Nordhoy as a person with significant control on 2026-03-24
Registered office address changed from The Scalpel 18th Floor 52 Lime Street London EC3M 7AF England to 55-56 Russell Square London WC1B 4HP on 2025-12-10
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
30/09/2026Filing deadline
Confirms the registry record is up to date
The latest figures IDEAPHARMA LTD filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
2023: £1.21M
Total Assets
2023: £2.07M
Cash in Bank
2023: £7.05K
Total Liabilities
2023: £831.02K
Employees
2023: 23
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Net assets moved furthest, up 336.17% on 2023. See the full financial analysis for IDEAPHARMA LTD.
The full financial record
Four ways through IDEAPHARMA LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 20 | -3 |
| 2023 | 23 | +3 |
| 2022 | 20 | +3 |
| 2021 | 17 | – |
Reported employee count increased from 17 in 2021 to 20 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 23/06/2009–09/04/2010 | 4 | |
| Director | 07/12/2000–12/11/2024 | 4 | |
| Director | 30/08/2007–30/09/2009 | 4 | |
| Nominee Secretary | 07/12/2000–07/12/2000 | 494 | |
| Director | 07/12/2000–30/08/2007 | 3 | |
| Secretary | 07/12/2000–30/08/2007 | 2 | |
| Director | 30/08/2007–14/04/2008 | 1 | |
| Secretary | 21/03/2012–24/04/2017 | 0 | |
| Director | 24/01/2025–Present | 1 | |
| Director | 12/11/2024–Present | 0 | |
| Director | 12/11/2024–24/01/2025 | 0 | |
| Secretary | 30/08/2007–30/09/2009 | 0 | |
| Secretary | 29/09/2009–21/03/2012 | 0 | |
| Director | 30/05/2023–12/11/2024 | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–12/11/2024 | 4 | |
| 06/04/2016–Present | 4 | |
| 05/04/2017–30/05/2017 | 0 | |
| 05/04/2017–30/05/2017 | 0 | |
| 06/04/2016–02/11/2023 | 3 | |
| 06/04/2016–Present | 3 | |
| 31/12/2024–Present | 0 |
Every document on the Companies House record, newest first.
Director's details changed for Anna Ellingboe on 2026-05-19
Notification of a person with significant control statement
Cessation of Erik Nordhoy as a person with significant control on 2026-03-24
Registered office address changed from The Scalpel 18th Floor 52 Lime Street London EC3M 7AF England to 55-56 Russell Square London WC1B 4HP on 2025-12-10
Total exemption full accounts made up to 2024-12-31
Confirmation statement made on 2025-06-21 with updates
Withdrawal of a person with significant control statement on 2025-03-24
Notification of Erik Nordhoy as a person with significant control on 2024-12-31
Statement of capital following an allotment of shares on 2024-11-12
Particulars of variation of rights attached to shares
Change of share class name or designation
Termination of appointment of Eugene Krichevsky as a director on 2025-01-24
Showing 12 of 93 filings
See when the next accounts and confirmation statement are due
177 UK companies are similar to IDEAPHARMA LTD, sharing the same company status (Active), the same industry sector and activity group (Management consultancy activities other than financial management) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
Old Tyrone Brick Factory Unit 2, Ranaghan, 11 Cookstown Road, Dungannon, Tyrone BT71 4BB
Rosemount House, 21-23 Sydenham Road, Belfast BT3 9HA
5th Floor North Side, 7-10 Chandos Street, Cavendish Square, London W1G 9DQ
White Rose House Otley Road, Headingley, Leeds LS6 2AD
20 Farringdon Street, 11th Floor, London EC4A 4AB
A short description of the company, written from its Companies House record.
IDEAPHARMA LTD is a private limited company registered in the United Kingdom, based in 55-56 Russell Square, London WC1B 4HP. Companies House classifies its business as Management consultancy activities other than financial management. It has been on the register for 25 years 9 months.
The register currently records it as active. Its 2024 accounts report net assets of £5.28M and 20 employees.
Answered from this company's own registry record and filed figures.
Companies House records IDEAPHARMA LTD under one registered business activity: Management consultancy activities other than financial management (70.22/9 - SIC 2007).
IDEAPHARMA LTD is recorded as active on the Companies House register, and has been on it since 07/12/2000.
The most recent accounts Okredo holds cover 2024 and report net assets of £5.28M, total assets of £5.78M, cash in bank of £365.81K and total liabilities of £483.12K.
The most recent document on the record is dated 09/06/2026: Director's details changed for Anna Ellingboe on 2026-05-19, 3 months ago.
On the current registry record, accounts are due by 30/09/2026.
Companies House lists 14 officers (2 currently in post) and 7 people with significant control (3 current).